Literature DB >> 20428786

Alleviation of hepatic oxidative stress by Chinese herbal medicine Yin-Chen-Hao-Tang in obese mice with steatosis.

Tzung-Yan Lee1, Hen-Hong Chang, Wen-Chai Lo, Han-Chieh Lin.   

Abstract

Obesity is associated with a complex systemic inflammatory state that has been implicated in the development of hepatic steatosis. This study was to test the efficacy of Yin-Chen-Hao-Tang (YCHT), an agent that improves hepatic triglyceride metabolism in its ability to modulate pathways implicated in hepatic steatosis. Mice were fed with high-fat diet for fifteen weeks. The therapeutic mechanism of YCHT likely enhanced adiponectin and endothelial progenitor cells, and up-regulation of peroxisome proliferator-activated receptor gamma might be responsible for fatty liver diseases. In addition, YCHT anti-oxidative stress effect might be associated with inhibition of hepatic free fatty acid concentrations and elevation of the glutathione levels in hepatic tissues. Furthermore, YCHT action mechanisms might promote senescence marker protein-30 metabolism that increase resistance to hepatic oxidative stress. These findings suggest a novel therapeutic approach for fatty liver progression in obesity mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20428786     DOI: 10.3892/ijmm_00000412

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  17 in total

Review 1.  Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

Authors:  Hui Dong; Fu-Er Lu; Li Zhao
Journal:  Chin J Integr Med       Date:  2012-02-05       Impact factor: 1.978

Review 2.  Drug metabolism alterations in nonalcoholic fatty liver disease.

Authors:  Matthew D Merrell; Nathan J Cherrington
Journal:  Drug Metab Rev       Date:  2011-05-25       Impact factor: 4.518

Review 3.  Herbal medicines and nonalcoholic fatty liver disease.

Authors:  Hong Yao; Yu-Jie Qiao; Ya-Li Zhao; Xu-Feng Tao; Li-Na Xu; Lian-Hong Yin; Yan Qi; Jin-Yong Peng
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 4.  Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Ke-Qing Shi; Yu-Chen Fan; Wen-Yue Liu; Ling-Fei Li; Yong-Ping Chen; Ming-Hua Zheng
Journal:  Mol Biol Rep       Date:  2012-06-21       Impact factor: 2.316

5.  Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang.

Authors:  Qiaoling Yang; Fan Yang; Xiaowen Tang; Lili Ding; Ying Xu; Yinhua Xiong; Zhengtao Wang; Li Yang
Journal:  BMC Complement Altern Med       Date:  2015-04-16       Impact factor: 3.659

Review 6.  A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease.

Authors:  Wei-Fan Hsu; Lee-Yan Sheen; Hung-Jen Lin; Hen-Hong Chang
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-31       Impact factor: 2.629

Review 7.  Therapeutic mechanism of Yīn-Chén-Hāo decoction in hepatic diseases.

Authors:  Jian-Yuan Li; Hong-Yan Cao; Lin Sun; Run-Fei Sun; Chao Wu; Yan-Qin Bian; Shu Dong; Ping Liu; Ming-Yu Sun
Journal:  World J Gastroenterol       Date:  2017-02-21       Impact factor: 5.742

8.  Protective Effect of a Novel Polysaccharide from Lonicera japonica on Cardiomyocytes of Mice Injured by Hydrogen Peroxide.

Authors:  Xiaonan Zhou; Gui He; Jinming Ma; Min Tang; Geng Tian; Xun Gong; Huajun Zhang; Ling Kui
Journal:  Biomed Res Int       Date:  2020-06-23       Impact factor: 3.411

9.  Protective effects of capillary artemisia polysaccharide on oxidative injury to the liver in rats with obstructive jaundice.

Authors:  Chang-Sheng He; Hong-Yi Yue; Jian Xu; Feng Xue; Jian Liu; Yuan-Yuan Li; Hong-En Jing
Journal:  Exp Ther Med       Date:  2012-08-14       Impact factor: 2.447

Review 10.  Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.

Authors:  Hor-Yue Tan; Serban San-Marina; Ning Wang; Ming Hong; Sha Li; Lei Li; Fan Cheung; Xiao-Yan Wen; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.